- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.11. | Glucotrack, Inc. Announces Closing of $10.0 Million Public Offering and Concurrent Private Placement Converting $4.0 in Outstanding Debt | 1 | GlobeNewswire (USA) | ||
| 13.11. | Glucotrack kündigt öffentliches Angebot von 10 Millionen US-Dollar an | 1 | Investing.com Deutsch | ||
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 13.11. | Glucotrack, Inc. Announces Pricing of $10.0 Million Public Offering | 2 | GlobeNewswire (USA) | ||
| 13.11. | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 04.11. | Glucotrack, Inc. - S-1/A, General form for registration of securities | - | SEC Filings | ||
| 24.10. | Glucotrack, Inc. - S-1/A, General form for registration of securities | 1 | SEC Filings | ||
| 22.10. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 01.10. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES ORAL & POSTER PRESENTATIONS AT THE 2024 DIABETES TECHNOLOGY MEETING | 3 | GlobeNewswire (USA) | ||
| 26.09. | Glucotrack-Aktionäre stimmen wichtigem Ausgabevorschlag zu | 2 | Investing.com Deutsch | ||
| 26.09. | Glucotrack shareholders approve pivotal issuance proposal | 1 | Investing.com | ||
| 26.09. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 23.09. | GlucoTrack files for $30M mixed securities shelf | 1 | Seeking Alpha | ||
| 23.09. | GlucoTrack files for $30M mixed securities she | 1 | Seeking Alpha | ||
| 16.09. | Glucotrack, Inc. - S-1, General form for registration of securities | 2 | SEC Filings | ||
| 10.09. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.09. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 03.09. | GlucoTrack, Inc.: JOHN BALLANTYNE, FORMER BIOTECHNOLOGY EXECUTIVE, JOINS THE GLUCOTRACK BOARD OF DIRECTORS | 1 | GlobeNewswire (USA) | ||
| 27.08. | Glucotrack appoints new VP for clinical trials | 1 | Investing.com | ||
| 27.08. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.08. | GlucoTrack, Inc.: GLUCOTRACK ANNOUNCES NEW VICE PRESIDENT OF CLINICAL OPERATIONS | 1 | GlobeNewswire (USA) |
Seite:
1 2 3 Weiter >>
44 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 37,000 | -0,38 % | EQS-News: Eckert & Ziegler SE: Eckert & Ziegler mit starken Neunmonatszahlen 2024 weiter auf Wachstumskurs | EQS-News: Eckert & Ziegler SE
/ Schlagwort(e): 9-Monatszahlen
Eckert & Ziegler mit starken Neunmonatszahlen 2024 weiter auf Wachstumskurs
14.11.2024 / 07:45 CET/CEST
Für... ► Artikel lesen | |
| SERNOVA | 0,159 | -1,37 % | Sernova Aktie: Fortschritte bei Cell Pouch System | Die kanadische Biotechnologiefirma Sernova verzeichnet bedeutende Entwicklungen bei ihrer innovativen Cell Pouch Technologie. Das Unternehmen, das sich auf regenerative Medizinlösungen für chronische... ► Artikel lesen | |
| SYNLAB | 11,460 | 0,00 % | Cinven secures Italian nod to sell minority stake in Synlab to Labcorp | ||
| NUGEN MEDICAL DEVICES | 0,059 | -0,34 % | NuGen Medical: Wichtige News und olympische Unterstützung für den InsuJet! | ||
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| UNIDOC HEALTH | 0,276 | -9,80 % | UniDoc Health Corp.: UniDoc Showcases H3 Health Cube in Italy | AI-equipped H3 Health Cube Displayed at the Annual Assembly of the National Association of Italian Municipalities VANCOUVER, BC / ACCESSWIRE / November 20, 2024 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn-based Wound Care Hydrogel | BOULDER, CO / ACCESSWIRE / November 11, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,010 | +2,02 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| QUIDELORTHO | 35,200 | -1,12 % | Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted | ||
| EMPOWER CLINICS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.07.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 30.07.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.07.2024ISIN NameCA29246V2030 EMPOWER... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 0,842 | -0,88 % | TPST Stock Plummets to 52-Week Low at $0.85 Amid Market Struggles | ||
| QUEST DIAGNOSTICS | 153,75 | +0,46 % | Quest Diagnostics-Aktie erreicht 52-Wochen-Hoch von 162,68 US-Dollar | ||
| VERU | 0,586 | -1,76 % | Veru Inc.: Veru Reaches Full Enrollment for Phase 2b QUALITY Clinical Study of Enobosarm for Obesity and Reports Fiscal 2024 Third Quarter Financial Results | --Phase 2b QUALITY study of enobosarm in combination with semaglutide (Wegovy®*) exceeds targeted full enrollment of >150 patients-- --Topline data for primary endpoint of lean body mass expected... ► Artikel lesen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,265 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.
